Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells

Heat shock protein 90 (HSP90) controls maturation of oncogenic client proteins of cancer cells, and thus we studied the effect of HSP 90 inhibitors on cell survival and survival-related mediators in thyroid carcinoma cells. Human TPC-1 and SW1736 thyroid carcinoma cells were utilized. Cell viability...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 40; no. 11; pp. 6137 - 6150
Main Authors KIM, SI HYOUNG, CHO, YUN KYUNG, HUH, JI HYE, KANG, JUN GOO, IHM, SUNG-HEE, CHOI, MOON GI, LEE, SEONG JIN
Format Journal Article
LanguageEnglish
Published Greece International Institute of Anticancer Research 01.11.2020
Subjects
Online AccessGet full text
ISSN0250-7005
1791-7530
1791-7530
DOI10.21873/anticanres.14634

Cover

More Information
Summary:Heat shock protein 90 (HSP90) controls maturation of oncogenic client proteins of cancer cells, and thus we studied the effect of HSP 90 inhibitors on cell survival and survival-related mediators in thyroid carcinoma cells. Human TPC-1 and SW1736 thyroid carcinoma cells were utilized. Cell viability, cytotoxic activity and apoptosis were estimated using CCK-8 assay, cytotoxicity assay and FACS analysis, respectively. AUY922, BIIB021 and SNX5422 decreased cell viability, and increased cytotoxic activity and the proportion of apoptotic cells. The protein levels of cleaved PARP, cleaved caspase-3, Bax and Bim were elevated, and Bcl2 protein levels were reduced. Knockdown of Bax did not change cell viability, cytotoxic activity, the proportion of apoptotic cells and cleaved caspase-3 protein levels. Meanwhile, knockdown of Bim enhanced cell viability, and diminished cytotoxic activity, the proportion of apoptotic cells and cleaved caspase-3 protein levels. AUY922, BIIB021 and SNX5422 increased the protein levels of phospho-AMPK, and decreased those of phospho-ERK1/2, and total and phospho-AKT. AUY922, BIIB021 and SNX5422 induce cytotoxicity by modulating Bim and ERK1/2, AKT and AMPK signaling in thyroid carcinoma cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0250-7005
1791-7530
1791-7530
DOI:10.21873/anticanres.14634